Fundraising Fox

Matthew Young

Investor

Managing Director at Longitude Capital · Vice President at Creandum · Board director at OrsoBio

Menlo Park

About

Managing Director who joined in 2022 after serving as COO/CFO of GRAIL and CFO of Jazz Pharmaceuticals. He focuses on biotechnology and holds an MBA and BS from Wharton.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Board director at OrsoBio

Intro paths

In turn, Matthew can intro founders to OrsoBio's investors below.

Experience

  1. CreandumVice Presidentcurrent2025 — present
  2. Balderton CapitalVisiting MBA Associate2025
  3. WorldpayProduct Strategy Manager2022 — 2023London, UK
  4. Goldman SachsInvestment Banking2020 — 2022London, UK

Skills & more

Microsoft Office5HTML5Cascading Style Sheets (CSS)5JavaScript4Venture CapitalFinancial ModelingStrategic ThinkingTeamwork6Growth Capital14Capital Raising9Venture Financing3Private Placements2
+3 moreMezzanineCapitalEntrepreneurship

Languages Deutsch · Englisch · Französisch · Russisch

  • PMC Level IVPragmatic Institute
  • Pragmatic Certified Product ManagerPragmatic Institute

From Matthew's professional profile.

Colleagues at Longitude Capital

Frequently asked questions

Who is Matthew Young?
Managing Director who joined in 2022 after serving as COO/CFO of GRAIL and CFO of Jazz Pharmaceuticals. He focuses on biotechnology and holds an MBA and BS from Wharton.
Where does Matthew Young work?
Matthew Young is Managing Director at Longitude Capital and Board director at OrsoBio.
What does Matthew Young invest in?
Matthew Young invests in Biotech, Healthtech, Medical Devices.
Where did Matthew Young go to school?
Matthew Young studied at Massachusetts Institute of Technology (Master of Business Administration - MBA); The London School of Economics and Political Science (LSE) (BSc Accounting & Finance); CJD Christophorusschule Droyssig (Abitur).

Same school

Shared employers